Get started
Author

Guillaume Escure

Observed names: Escure Guillaume, G. Escure
Observed institutions: Centre National de la Recherche Scientifique, Inserm, Université de Lille, Centre Hospitalier Universitaire de Lille, Hôpital Claude Huriez, Centre de Recherches en Cancérologie de Lille
ORCID: 0000-0002-3151-9441
Observed ORCID: 0000-0002-3151-9441
OpenAlex ID: A5035488811
Current state and next-generation CAR-T cells in multiple myeloma
2022 · Salomon Manier, Tiziano Ingegnere, et al. · Blood Reviews · 118
PDF
Deregulation and Targeting of TP53 Pathway in Multiple Myeloma
2019 · Katarina K. Jovanović, Guillaume Escure, et al. · Frontiers in Oncology · 91
PDF
Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study
2024 · Aurélie Jourdes, Elise Cellerin, et al. · Clinical Microbiology and Infection · 89
PDF
Treatment with temozolomide and ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL)
2021 · Loïc Renaud, Jean Baptiste Bossard, et al. · European Journal Of Haematology · 36
Discontinuation of antimicrobial therapy in adult neutropenic haematology patients: A prospective cohort
2019 · Zoé Van de Wyngaert, Céline Berthon, et al. · International Journal of Antimicrobial Agents · 25
PDF
Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression
2024 · Léa Fléchon, Inès Arib, et al. · Blood Advances · 22
PDF
Small myeloid subclones are present at diagnosis of multiple myeloma in patients who develop secondary myelodysplastic syndromes
2023 · Guillaume Escure, Elise Fournier, et al. · Haematologica · 6
PDF
Case Report: Two Cases of Cryptosporidiosis in Heavily Pretreated Patients With Myeloma
2021 · Jordane Demonchy, Camille Cordier, et al. · Clinical Lymphoma Myeloma & Leukemia · 6
Clinical benefit of tafasitamab plus lenalidomide in relapsed or refractory diffuse large Bcell lymphoma: real-world data from the EarlyMIND study
2025 · Gabriel Brisou, Jérôme Paillassa, et al. · Haematologica · 5
Cumulative Incidence and Characteristics of Infections Requiring Treatment, Delay in Treatment Administration or Hospitalisation in Patients with Relapsed or Refractory Multiple Myeloma Treated with Anti BCMA or Anti GPRC5D Bispecific Antibodies
2023 · Elise Cellerin, Aurelie Jourdes, et al. · Blood · 5
Tolerance of bradykinin-releasing drugs in patients with acquired C1 inhibitor deficiency: a case series and review of the literature
2022 · Guillaume Escure, Morgane Nudel, et al. · European Journal of Dermatology · 2
Myélome multiple et anticorps bispécifiques
2021 · Guillaume Escure, Salomon Manier · Bulletin du Cancer · 2
PDF
Inflammatory bone marrow microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myeloma
2026 · Wenwen Cheng, Silvia Gaggero, et al. · Biomarker Research · 1
PDF
L’électrophorèse des protéines sériques : quand ? Pourquoi ? Quels orientation et suivi ?
2022 · Guillaume Escure, Salomon Manier, et al. · La Presse Médicale Formation · 1
PDF
Antibody-drug conjugate in multiple myeloma
2021 · Escure Guillaume, Salomon Manier · Hématologie · 1
PDF
Real‐world safety and efficacy of apixaban versus standard thromboprophylaxis in newly diagnosed multiple myeloma: Insights from a multicentre retrospective cohort study
2026 · Guillaume Escure, Corinne Frere, et al. · British Journal of Haematology
Cutaneous mucormycosis in an immunosuppressed patient
2023 · M. Boileau, G. Escure, et al. · Annales de Dermatologie et de Vénéréologie
PDF
P1217: Intrathecal Methotrexate Prophylaxis and Central Nervous System Relapse in Patients With Diffuse Large B-cell Lymphoma Treated With Intensified R-acvbp Strategy
2022 · L. Renaud, P. Stéphan, et al. · HemaSphere
P851: Targeting Gene Dependencies in Myc Overexpressing Multiple Myeloma
2022 · L. Hasan Bou Issa, L. Fléchon, et al. · HemaSphere
Tolérance des médicaments inducteurs de crises d’angiœdème bradykinique chez les patients atteints de déficit acquis en C1-inhibiteur : série de cas et revue de la littérature
2021 · G. Escure, M. Nudel, et al. · La Revue de Médecine Interne
SC VHE chez patient allogreffé CHU Lille : enquête d’hémovigilance
2019 · Danièle Lagniez, Imen Saidi, et al. · Transfusion Clinique et Biologique
Works count: 21
Citation count: 410
H-index: 6
I10-index: 6
Year
Topic
Type